AMGN Jun 2024 200.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:15PM EDT. Market open.
| Previous Close | 73.48 |
| Open | 73.48 |
| Bid | 67.85 |
| Ask | 71.15 |
| Strike | 200.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 73.48 - 73.48 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 25 |
PR NewswireAMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Amgen (NASDAQ:AMGN) today announced financial results for the first quarter 2024.
- Baystreet
TSX Wobbles at Thursday Open
Equities in Toronto waned at the open, despite a surge in technology shares, as positive comments ...
ReutersAmgen investors await weight-loss drug data
(Reuters) -Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company may provide on its own weight-loss drug candidates when it reports quarterly earnings on Thursday. Amgen has said it expects to have first-in-human results from a small, early-stage trial of experimental oral compound AMG786 before the end of June. "We are still collecting and analyzing the data," Amgen Chief Scientific Officer Jay Bradner told Reuters in an interview.
© 2024 Yahoo. All rights reserved.